|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| A61K 33/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 4114465 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22724683.2 |
| Date of filing the European patent application | 2022-04-21 | |
| (97) | Date of publication of the European application | 2023-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation | 2023-11-10 |
| (86) | Number | PCT/EP2022/060592 |
| Date | 2022-04-21 |
| (87) | Number | WO 2022/223714 |
| Date | 2022-10-27 |
| (30) | Number | Date | Country code |
| 202163178739 P | 2021-04-23 | US | |
| 202163245285 P | 2021-09-17 | US | |
| 202163272851 P | 2021-10-28 | US |
| (72) |
LINDHOLM, Catharina , SE
CHIA, Yen Lin , US
TUMMALA, Rajendra , US
ROSKOS, Lorin , US
ALMQUIST, Joachim , SE
ROUSE, Tomas , SE
|
| (73) |
AstraZeneca AB ,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-IFNAR1 dozavimo režimas, skirtas poodinei injekcijai |
| ANTI-IFNAR1 DOSING REGIME FOR SUBCUTANEOUS INJECTION |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 4 | 92.00 EUR |
| 2026-04-21 |